New York, New York (PRWEB) June 20, 2014
Bayer Healthcare Pharmaceuticals, a company already named a defendant in hundreds of Mirena IUD lawsuits (http://www.themirenalawsuitcenter.com/) that allege injury due to spontaneous migration of the device, has voiced its opposition to a plaintiffs’ motion seeking consolidation of federally-filed Mirena brain injury claims, Bernstein Liebhard LLP reports. In a response filed with the U.S. Judicial Panel on Multidistrict Litigation (JPML) on June 17th, Bayer maintains that there are too few such claims pending in federal courts to warrant the creation of a multidistrict litigation. The company points out that only 10 claims have been filed so far that allege the Levonorgestrel released by the Mirena IUD can result in non-stroke neurological complications, including pseudotumor cerebri (PTC, also known as idiopathic intracranial hypertension or IIH). Court documents indicate that the JPML will hear oral arguments on this matter on July 31, 2014 in Kansas City. Kansas. (In RE: Mirena IUD Levonorgestrel-Related Products Liability Litigation, Pending No. 63)
“This matter is of great interest to our Firm, as we are representing numerous women who allegedly suffered serious Mirena complications due to spontaneous migration of the IUD,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free case evaluations to women who were allegedly harmed after their Mirena IUD spontaneously migrated from its proper position in the uterus.
Mirena IUD Lawsuits
Court documents indicate that Bayer Healthcare Pharmaceuticals has been named in more than 1,200 Mirena lawsuits filed on behalf of women who were allegedly injured as a result of spontaneous device migration. These include 569 cases that are currently pending in a federal multidistrict litigation underway in U.S. District Court, Southern District of New York. (In re: Mirena IUD Products Liability Litigation, MDL No. 2434) An additional 729 Mirena claims are pending in a multicounty litigation underway in New Jersey’s Bergen County Superior Court, where Bernstein Liebhard LLP is actively filing lawsuits. (In Re: Mirena Litigation; Case No. 297)
According to court records, all of the Mirena lawsuits pending in these two proceedings accuse Bayer of failing to provide adequate warnings about the risk of spontaneous migration, and point out that the product’s label only warns that migration may occur if the uterus is perforated upon insertion. Plaintiffs also claim that Bayer has a history of overstating the IUD’s benefits and understating the risks of serious Mirena injuries.
The Mirena IUD was brought to market in 2000 and is now approved as both a contraceptive and as a treatment for heavy menstrual bleeding in women who wish to use an IUD for contraception. In December 2009, the U.S. Food & Drug Administration (FDA) issued a Warning Letter to Bayer Healthcare Pharmaceuticals after finding that one of the company’s Mirena promotions made misleading claims about the safety and efficacy of the IUD.
Women who allegedly suffered uterine perforations, scarring, ectopic pregnancy, organ damage and other Mirena complications related to spontaneous IUD migration may be entitled to compensation for their injury-related damages. To learn more about the litigation involving Mirena IUD lawsuits, please visit Bernstein Liebhard LLP’s website, or visit the Firm’s Facebook page: https://www.facebook.com/mirenalawsuithelp. For a free legal consultation, please call 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP represents the victims of defective drugs and medical devices on a contingency-fee basis, and our clients are never expected to pay attorneys fees unless their case results in a successful recovery on their behalf. New York State’s contingency fee cap rules generally limit those fees to 33 1/3% of the total recovery. As a result, the Firm’s fees can be significantly lower than those assessed by attorneys in other states, which depending on the law may amount to as much as 40% or more of a plaintiff’s recovery.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com